Which Mounjaro dose is most effective for weight loss?

The biggest misconception: that 2.5mg isn't doing anything

It is genuinely one of the most common worries people bring to their prescribers. You start Mounjaro at 2.5mg, a month passes, and the scales haven't moved much. The instinct is to assume the medicine isn't working, or that you need to jump straight to 10mg to see results.

The truth is that 2.5mg was never designed to be a therapeutic weight-loss dose. Its job is adjustment. Tirzepatide activates two gut-hormone receptors simultaneously, which is why the GI side effects (nausea, stomach discomfort, loose stools in some people) can be noticeable at first. Starting low gives your digestive system time to settle before the dose does the heavier lifting. The NHS patient guide to tirzepatide explains this clearly: titration exists to manage tolerability, not to delay results.

Let that worry go gently, because it can lead people to rush the schedule in ways that increase side effects without meaningfully improving outcomes. Staying at each dose for the recommended period is part of what makes the medicine work safely.

If you'd like to understand whether even the lowest tirzepatide doses are doing meaningful work in the body, that question is worth exploring before drawing conclusions about your progress. And our page on whether 2.5mg Mounjaro is effective goes into more detail about what this starting dose typically contributes on its own.

What the trial data actually show across doses

SURMOUNT-1 (a 72-week phase 3 trial of 2,539 adults with obesity and without diabetes) is the foundational evidence for Mounjaro's weight-loss licence in the UK. Participants were randomised to 5mg, 10mg or 15mg tirzepatide, or placebo, alongside lifestyle support. Average weight reductions were approximately 15% at 5mg, 19.5% at 10mg and 20–21% at 15mg, compared with around 3% on placebo. The SURMOUNT-1 paper, published in the New England Journal of Medicine, contains the full breakdown.

A few things stand out in those numbers. First, the gap between 10mg and 15mg is smaller than the gap between placebo and 5mg, the curve flattens at higher doses. Second, individual variation is substantial; some participants at 5mg lost more than the average at 15mg. Third, tolerability played a role in who reached and stayed at the higher doses.

NICE's appraisal of tirzepatide, published as TA1026, draws on this data when recommending the medicine for eligible adults, and notes that if less than 5% of body weight is lost after six months at the highest tolerated dose, continuing should be reviewed. That 'highest tolerated' phrasing matters: the goal is the highest dose you can sustain comfortably, not simply the highest dose available.

For a closer look at how 5mg performs specifically, our page on 5mg Mounjaro effectiveness covers the evidence in detail.

Why 'highest tolerated' is the right way to think about this

The dose that produces the best outcome for you is the one you can stay on. That sounds obvious, but it has real clinical implications. Forcing a rapid increase to 15mg when your body is still adapting at 7.5mg tends to produce more side effects, which can lead to pausing treatment, and pausing treatment interrupts progress more than a slower titration would have done.

Prescribers at a service like ours at nume look at several things when a dose review comes around: how much weight you have lost so far, how well you have tolerated the current dose, and whether there are any clinical reasons to move more cautiously. That review happens before every repeat, not as a formality.

If you're curious about how dose choices compare in terms of weight-loss trajectory, our overview of which Mounjaro dose tends to produce the best weight-loss results sets out the clinical thinking behind the schedule. And if you want to understand the broader picture of how Mounjaro works as a treatment, our Mounjaro information page covers the mechanism, eligibility and what to expect.

What this means before you start treatment

Clinical assessment comes first. Mounjaro is a prescription-only medicine, and the schedule (2.5mg upward in roughly four-week steps) is set by your prescriber based on your clinical picture, not selected from a menu. The published average weight-loss figures give a useful reference point, but they describe thousands of people; your result depends on your biology, your adherence, your lifestyle changes alongside treatment, and how your body responds at each dose. If you want to understand how the evidence shapes expectations at different points in the schedule, our page on what dose of Mounjaro is most effective walks through what the data show at each stage.

People often ask about cost alongside effectiveness, and it's a fair question, higher doses do cost more on the private market. Our page on the cost and structure of weight-loss treatments at nume sets out what is included in a single transparent price, including the clinical reviews that govern dose changes. Knowing what you're paying for at each step makes the whole process easier to plan.

If you're ready to find out whether Mounjaro is clinically suitable for you, you can check your eligibility through a free consultation with our prescribers. A real clinician reads your answers the same day, no algorithm, no waiting list.